NCT00515892View on ClinicalTrials.gov

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2007

Conditions
LeukemiaNon-Hodgkin's LymphomaNHL
Interventions
DRUG

Immunotoxin therapy

DRUG

CAT-8015 Immunotoxin

PROCEDURE

Biological therapy

PROCEDURE

Antibody Therapy

PROCEDURE

Monoclonal Antibody Therapy

Trial Locations (3)

20892

RECRUITING

Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

90211

RECRUITING

Tower Hematology Oncology Medical Group, Beverly Hills

Unknown

NOT_YET_RECRUITING

Klinika Hamtologii Uniwersytetu Medycznego (Medical University of Lodz), Lodz

Sponsors
All Listed Sponsors
lead

Cambridge Antibody Technology

OTHER

NCT00515892 - Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease | Biotech Hunter | Biotech Hunter